Technical Analysis for GBT - Global Blood Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 58.875 0.97% 0.57
GBT closed up 2.75 percent on Tuesday, May 21, 2019, on 54 percent of normal volume.
5 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical GBT trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.97%
180 Bullish Setup Bullish Swing Setup 0.97%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.97%
Multiple of Ten Bearish Other 0.52%
Inside Day Range Contraction 0.52%
Upper Bollinger Band Touch Strength 0.52%
New 52 Week Closing High Bullish -3.15%
Pocket Pivot Bullish Swing Setup -3.15%
New 52 Week High Strength -3.15%
Multiple of Ten Bullish Other -3.15%

Older signals for GBT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:
Profile
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous blood-based disorders. Its product candidate is GBT440, a hemoglobin modifier that binds to hemoglobin molecules, which is in double-blind Phase I/II clinical trial indicated for the treatment of sickle cell disease. The company also focuses on developing an oral prophylactic therapy for hypoxemic pulmonary disorders and hereditary angioedema. The company was founded in 2011 and is based in South San Francisco, California.
Medicine Biopharmaceutical Medical Specialties Blood Hereditary Angioedema Sickle Cell Disease Angioedema Hemoglobin
Is GBT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 17 The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering
May 16 GBT Announces Upcoming Data Presentations at 24th European Hematology Association (EHA) Congress Supporting Voxelotor Sickle Cell Disease Program
May 15 Global Blood Remains On Track For Transformational Year
May 10 Global Blood (GBT) Reports Narrower-Than-Expected Loss in Q1
May 8 Global Blood: 1Q Earnings Snapshot
May 8 Global Blood Therapeutics beats by $0.06
May 8 GBT Reports Recent Business Progress and First Quarter 2019 Financial Results
May 8 When Will Global Blood Therapeutics, Inc. (NASDAQ:GBT) Breakeven?
May 1 Did Hedge Funds Drop The Ball On Global Blood Therapeutics Inc (GBT) ?
Apr 4 The Daily Biotech Pulse: Recro Restructures, Biotechs Raise Proceeds In Droves, Silk Road, NGM Biopharma To Debut
See more GBT news...
Indicators
Indicator Value
52 Week High 62.5
52 Week Low 30.15
Average Volume 625,352
200-Day Moving Average 46.1336
50-Day Moving Average 55.4314
20-Day Moving Average 56.6285
10-Day Moving Average 57.892
Average True Range 2.6395
ADX 17.34
+DI 24.255
-DI 18.0339
Chandelier Exit (Long, 3 ATRs ) 54.5815
Chandelier Exit (Short, 3 ATRs ) 60.5185
Upper Bollinger Band 60.231
Lower Bollinger Band 53.026
Percent B (%b) 0.73
BandWidth 12.723275
MACD Line 0.8022
MACD Signal Line 0.706
MACD Histogram 0.0962
Fundamentals Value
Market Cap 2.55 Billion
Num Shares 43.7 Million
EPS -2.46
Price-to-Earnings (P/E) Ratio -23.70
Price-to-Sales 0.00
Price-to-Book 5.19
PEG Ratio -0.38
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 61.21
Resistance 3 (R3) 60.93 59.68 60.72
Resistance 2 (R2) 59.68 58.95 59.82 60.56
Resistance 1 (R1) 59.00 58.49 59.34 59.28 60.40
Pivot Point 57.75 57.75 57.93 57.89 57.75
Support 1 (S1) 57.07 57.02 57.41 57.35 56.22
Support 2 (S2) 55.82 56.56 55.96 56.06
Support 3 (S3) 55.14 55.82 55.90
Support 4 (S4) 55.42